1例红细胞原卟啉症患者接种SARS-CoV-2疫苗后肝脏复发

Rare Pub Date : 2025-01-01 DOI:10.1016/j.rare.2025.100097
Francesca Granata , Simona Leoni , Valeria Di Stefano , Anna Ludovica Fracanzani , Giovanna Graziadei
{"title":"1例红细胞原卟啉症患者接种SARS-CoV-2疫苗后肝脏复发","authors":"Francesca Granata ,&nbsp;Simona Leoni ,&nbsp;Valeria Di Stefano ,&nbsp;Anna Ludovica Fracanzani ,&nbsp;Giovanna Graziadei","doi":"10.1016/j.rare.2025.100097","DOIUrl":null,"url":null,"abstract":"<div><div>Erythropoietic protoporphyria (EPP) is a rare genetic disorder that can lead to liver complications in a subset of patients. We describe the case of a 36-year-old woman with genetically confirmed EPP who developed acute liver injury following the second and booster doses of the Pfizer-BioNTech SARS-Cov-2 vaccine. The clinical course included elevated liver enzymes and PPIX levels, thrombocytopenia, reactivation of autoimmune markers, and worsening liver stiffness. No other causes were identified. Statistical analysis confirmed significant biochemical changes post-vaccination. This case suggests a possible immune-mediated hepatic response triggered by vaccination in a genetically predisposed individual.</div></div>","PeriodicalId":101058,"journal":{"name":"Rare","volume":"3 ","pages":"Article 100097"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Recurrent hepatic flares after SARS-CoV-2 vaccination in a patient with erythropoietic protoporphyria: A case report\",\"authors\":\"Francesca Granata ,&nbsp;Simona Leoni ,&nbsp;Valeria Di Stefano ,&nbsp;Anna Ludovica Fracanzani ,&nbsp;Giovanna Graziadei\",\"doi\":\"10.1016/j.rare.2025.100097\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Erythropoietic protoporphyria (EPP) is a rare genetic disorder that can lead to liver complications in a subset of patients. We describe the case of a 36-year-old woman with genetically confirmed EPP who developed acute liver injury following the second and booster doses of the Pfizer-BioNTech SARS-Cov-2 vaccine. The clinical course included elevated liver enzymes and PPIX levels, thrombocytopenia, reactivation of autoimmune markers, and worsening liver stiffness. No other causes were identified. Statistical analysis confirmed significant biochemical changes post-vaccination. This case suggests a possible immune-mediated hepatic response triggered by vaccination in a genetically predisposed individual.</div></div>\",\"PeriodicalId\":101058,\"journal\":{\"name\":\"Rare\",\"volume\":\"3 \",\"pages\":\"Article 100097\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rare\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2950008725000419\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rare","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950008725000419","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

红细胞生成原卟啉症(EPP)是一种罕见的遗传性疾病,可导致肝脏并发症的患者亚群。我们描述了一名36岁的遗传确诊EPP的女性,她在第二次和加强剂量的辉瑞- biontech SARS-Cov-2疫苗后出现急性肝损伤。临床过程包括肝酶和PPIX水平升高、血小板减少、自身免疫标记物再激活和肝僵硬恶化。没有发现其他原因。统计分析证实接种后的生化变化显著。本病例提示,在遗传易感个体中,接种疫苗可能引发免疫介导的肝脏反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Recurrent hepatic flares after SARS-CoV-2 vaccination in a patient with erythropoietic protoporphyria: A case report
Erythropoietic protoporphyria (EPP) is a rare genetic disorder that can lead to liver complications in a subset of patients. We describe the case of a 36-year-old woman with genetically confirmed EPP who developed acute liver injury following the second and booster doses of the Pfizer-BioNTech SARS-Cov-2 vaccine. The clinical course included elevated liver enzymes and PPIX levels, thrombocytopenia, reactivation of autoimmune markers, and worsening liver stiffness. No other causes were identified. Statistical analysis confirmed significant biochemical changes post-vaccination. This case suggests a possible immune-mediated hepatic response triggered by vaccination in a genetically predisposed individual.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信